THOMAS F ACKERMAN Insider Trading $CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS F ACKERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS F ACKERMAN. THOMAS F ACKERMAN is Corp. Executive VP & CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL) and Corp. Sr. VP & CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL) and Senior VP & CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL) and Sr. Vp and CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL).
THOMAS F ACKERMAN in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Trading Symbol: CRLIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of THOMAS F ACKERMAN: Corp. Executive VP & CFO, Corp. Sr. VP & CFO, Senior VP & CFO, Sr. Vp and CFO
Holdings: 104,211 shares
Current Value: $8,605,744
Latest Transaction: Feb 18 2015
$CRL Market Capitalization: $3.90B
$CRL Previous Close: $82.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of THOMAS F ACKERMAN in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 24 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 52.42 | 200 | 10,484 | 112,489 | 112.7 K to 112.5 K (-0.18 %) |
Dec 24 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 24.80 | 8,150 | 202,120 | 112,689 | 104.5 K to 112.7 K (+7.80 %) |
Dec 24 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Gift | G | 0.00 | 500 | 0 | 104,539 | 105 K to 104.5 K (-0.48 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 46.60 | 31,650 | 1,474,890 | 0 | |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.80 | 100 | 5,180 | 105,039 | 105.1 K to 105 K (-0.10 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.79 | 300 | 15,537 | 105,139 | 105.4 K to 105.1 K (-0.28 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.77 | 500 | 25,885 | 105,439 | 105.9 K to 105.4 K (-0.47 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.72 | 400 | 20,688 | 105,939 | 106.3 K to 105.9 K (-0.38 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.71 | 200 | 10,342 | 106,339 | 106.5 K to 106.3 K (-0.19 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.60 | 6,600 | 340,560 | 106,539 | 113.1 K to 106.5 K (-5.83 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.53 | 237 | 12,213 | 113,139 | 113.4 K to 113.1 K (-0.21 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.52 | 1,000 | 51,520 | 113,376 | 114.4 K to 113.4 K (-0.87 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.51 | 300 | 15,453 | 114,376 | 114.7 K to 114.4 K (-0.26 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 51.50 | 22,013 | 1,133,670 | 114,676 | 136.7 K to 114.7 K (-16.10 %) |
Nov 25 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 46.60 | 31,650 | 1,474,890 | 136,689 | 105 K to 136.7 K (+30.13 %) |
Nov 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 43.07 | 20,200 | 870,014 | 0 | |
Nov 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 50.00 | 20,200 | 1,010,000 | 105,039 | 125.2 K to 105 K (-16.13 %) |
Nov 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 43.07 | 20,200 | 870,014 | 125,239 | 105 K to 125.2 K (+19.23 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.86 | 100 | 4,986 | 105,039 | 105.1 K to 105 K (-0.10 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.81 | 100 | 4,981 | 105,139 | 105.2 K to 105.1 K (-0.10 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.80 | 200 | 9,960 | 105,239 | 105.4 K to 105.2 K (-0.19 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.80 | 100 | 4,980 | 105,439 | 105.5 K to 105.4 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.78 | 100 | 4,978 | 105,539 | 105.6 K to 105.5 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.76 | 300 | 14,928 | 105,639 | 105.9 K to 105.6 K (-0.28 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.75 | 300 | 14,925 | 105,939 | 106.2 K to 105.9 K (-0.28 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.74 | 200 | 9,948 | 106,239 | 106.4 K to 106.2 K (-0.19 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.73 | 200 | 9,946 | 106,439 | 106.6 K to 106.4 K (-0.19 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.73 | 100 | 4,973 | 106,639 | 106.7 K to 106.6 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.71 | 600 | 29,826 | 106,739 | 107.3 K to 106.7 K (-0.56 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.70 | 200 | 9,940 | 107,339 | 107.5 K to 107.3 K (-0.19 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.69 | 200 | 9,938 | 107,539 | 107.7 K to 107.5 K (-0.19 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.68 | 200 | 9,936 | 107,739 | 107.9 K to 107.7 K (-0.19 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.67 | 200 | 9,934 | 107,939 | 108.1 K to 107.9 K (-0.18 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.66 | 100 | 4,966 | 108,139 | 108.2 K to 108.1 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.65 | 100 | 4,965 | 108,239 | 108.3 K to 108.2 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.64 | 200 | 9,928 | 108,339 | 108.5 K to 108.3 K (-0.18 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.63 | 600 | 29,778 | 108,539 | 109.1 K to 108.5 K (-0.55 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.62 | 200 | 9,924 | 109,139 | 109.3 K to 109.1 K (-0.18 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.61 | 400 | 19,844 | 109,339 | 109.7 K to 109.3 K (-0.36 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.60 | 587 | 29,115 | 109,739 | 110.3 K to 109.7 K (-0.53 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.59 | 313 | 15,522 | 110,326 | 110.6 K to 110.3 K (-0.28 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.59 | 100 | 4,959 | 110,639 | 110.7 K to 110.6 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.58 | 200 | 9,916 | 110,739 | 110.9 K to 110.7 K (-0.18 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.57 | 800 | 39,656 | 110,939 | 111.7 K to 110.9 K (-0.72 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.56 | 1,000 | 49,560 | 111,739 | 112.7 K to 111.7 K (-0.89 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.56 | 100 | 4,956 | 112,739 | 112.8 K to 112.7 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.55 | 600 | 29,730 | 112,839 | 113.4 K to 112.8 K (-0.53 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.54 | 100 | 4,954 | 113,439 | 113.5 K to 113.4 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 24.80 | 15,000 | 372,000 | 38,150 | |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.53 | 300 | 14,859 | 113,539 | 113.8 K to 113.5 K (-0.26 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.52 | 100 | 4,952 | 113,839 | 113.9 K to 113.8 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.51 | 200 | 9,902 | 113,939 | 114.1 K to 113.9 K (-0.18 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.50 | 100 | 4,950 | 114,139 | 114.2 K to 114.1 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.49 | 300 | 14,847 | 114,239 | 114.5 K to 114.2 K (-0.26 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.48 | 100 | 4,948 | 114,539 | 114.6 K to 114.5 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.48 | 200 | 9,895 | 114,639 | 114.8 K to 114.6 K (-0.17 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.47 | 400 | 19,788 | 114,839 | 115.2 K to 114.8 K (-0.35 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.47 | 100 | 4,947 | 115,239 | 115.3 K to 115.2 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.46 | 100 | 4,946 | 115,339 | 115.4 K to 115.3 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.45 | 400 | 19,780 | 115,439 | 115.8 K to 115.4 K (-0.35 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.44 | 100 | 4,944 | 115,839 | 115.9 K to 115.8 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.43 | 100 | 4,943 | 115,939 | 116 K to 115.9 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.42 | 700 | 34,594 | 116,039 | 116.7 K to 116 K (-0.60 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.41 | 400 | 19,764 | 116,739 | 117.1 K to 116.7 K (-0.34 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.38 | 100 | 4,938 | 117,139 | 117.2 K to 117.1 K (-0.09 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.37 | 500 | 24,685 | 117,239 | 117.7 K to 117.2 K (-0.42 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.36 | 400 | 19,744 | 117,739 | 118.1 K to 117.7 K (-0.34 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.35 | 100 | 4,935 | 118,139 | 118.2 K to 118.1 K (-0.08 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.34 | 400 | 19,736 | 118,239 | 118.6 K to 118.2 K (-0.34 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.34 | 100 | 4,934 | 118,639 | 118.7 K to 118.6 K (-0.08 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.32 | 100 | 4,932 | 118,739 | 118.8 K to 118.7 K (-0.08 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.30 | 400 | 19,720 | 118,839 | 119.2 K to 118.8 K (-0.34 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.27 | 100 | 4,927 | 119,239 | 119.3 K to 119.2 K (-0.08 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.24 | 100 | 4,924 | 119,339 | 119.4 K to 119.3 K (-0.08 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.23 | 100 | 4,923 | 119,439 | 119.5 K to 119.4 K (-0.08 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.22 | 100 | 4,922 | 119,539 | 119.6 K to 119.5 K (-0.08 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.21 | 399 | 19,635 | 119,639 | 120 K to 119.6 K (-0.33 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 49.20 | 1 | 49 | 120,038 | 120 K to 120 K (0.00 %) |
Nov 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 49.53 | 15,000 | 743,012 | 120,039 | 105 K to 120 K (+14.28 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.47 | 100 | 4,647 | 105,039 | 105.1 K to 105 K (-0.10 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.46 | 200 | 9,292 | 105,139 | 105.3 K to 105.1 K (-0.19 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.45 | 100 | 4,645 | 105,339 | 105.4 K to 105.3 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.44 | 200 | 9,288 | 105,439 | 105.6 K to 105.4 K (-0.19 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.43 | 300 | 13,929 | 105,639 | 105.9 K to 105.6 K (-0.28 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.42 | 700 | 32,494 | 105,939 | 106.6 K to 105.9 K (-0.66 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.41 | 400 | 18,564 | 106,639 | 107 K to 106.6 K (-0.37 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.40 | 1,000 | 46,400 | 107,039 | 108 K to 107 K (-0.93 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.39 | 1,200 | 55,668 | 108,039 | 109.2 K to 108 K (-1.10 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.38 | 754 | 34,971 | 109,239 | 110 K to 109.2 K (-0.69 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.38 | 100 | 4,638 | 109,993 | 110.1 K to 110 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.37 | 300 | 13,911 | 110,093 | 110.4 K to 110.1 K (-0.27 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.36 | 700 | 32,452 | 110,393 | 111.1 K to 110.4 K (-0.63 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.36 | 100 | 4,636 | 111,093 | 111.2 K to 111.1 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.35 | 200 | 9,270 | 111,193 | 111.4 K to 111.2 K (-0.18 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.35 | 20 | 927 | 111,393 | 111.4 K to 111.4 K (-0.02 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.34 | 800 | 37,072 | 111,413 | 112.2 K to 111.4 K (-0.71 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.33 | 1,300 | 60,229 | 112,213 | 113.5 K to 112.2 K (-1.15 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.33 | 126 | 5,837 | 113,513 | 113.6 K to 113.5 K (-0.11 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.32 | 200 | 9,264 | 113,639 | 113.8 K to 113.6 K (-0.18 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.32 | 100 | 4,632 | 113,839 | 113.9 K to 113.8 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 24.80 | 15,000 | 372,000 | 53,150 | |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.32 | 100 | 4,632 | 113,939 | 114 K to 113.9 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.31 | 709 | 32,834 | 114,039 | 114.7 K to 114 K (-0.62 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.30 | 300 | 13,890 | 114,748 | 115 K to 114.7 K (-0.26 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.30 | 91 | 4,213 | 115,048 | 115.1 K to 115 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.28 | 100 | 4,628 | 115,139 | 115.2 K to 115.1 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.25 | 100 | 4,625 | 115,239 | 115.3 K to 115.2 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.24 | 100 | 4,624 | 115,339 | 115.4 K to 115.3 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.22 | 200 | 9,244 | 115,439 | 115.6 K to 115.4 K (-0.17 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.21 | 900 | 41,589 | 115,639 | 116.5 K to 115.6 K (-0.77 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.20 | 300 | 13,860 | 116,539 | 116.8 K to 116.5 K (-0.26 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.19 | 200 | 9,238 | 116,839 | 117 K to 116.8 K (-0.17 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.18 | 100 | 4,618 | 117,039 | 117.1 K to 117 K (-0.09 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.17 | 200 | 9,234 | 117,139 | 117.3 K to 117.1 K (-0.17 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.15 | 300 | 13,845 | 117,339 | 117.6 K to 117.3 K (-0.26 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.13 | 200 | 9,226 | 117,639 | 117.8 K to 117.6 K (-0.17 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.12 | 100 | 4,612 | 117,839 | 117.9 K to 117.8 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.11 | 100 | 4,611 | 117,939 | 118 K to 117.9 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.09 | 300 | 13,827 | 118,039 | 118.3 K to 118 K (-0.25 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.07 | 100 | 4,607 | 118,339 | 118.4 K to 118.3 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.03 | 200 | 9,206 | 118,439 | 118.6 K to 118.4 K (-0.17 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.02 | 100 | 4,602 | 118,639 | 118.7 K to 118.6 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 45.97 | 300 | 13,791 | 118,739 | 119 K to 118.7 K (-0.25 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 45.94 | 100 | 4,594 | 119,039 | 119.1 K to 119 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 45.93 | 100 | 4,593 | 119,139 | 119.2 K to 119.1 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 45.92 | 100 | 4,592 | 119,239 | 119.3 K to 119.2 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 45.90 | 100 | 4,590 | 119,339 | 119.4 K to 119.3 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 45.86 | 200 | 9,172 | 119,439 | 119.6 K to 119.4 K (-0.17 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 45.81 | 100 | 4,581 | 119,639 | 119.7 K to 119.6 K (-0.08 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 45.80 | 300 | 13,740 | 119,739 | 120 K to 119.7 K (-0.25 %) |
Sep 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 46.28 | 15,000 | 694,182 | 120,039 | 105 K to 120 K (+14.28 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 38.03 | 26,250 | 998,288 | 0 | |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.13 | 400 | 18,452 | 105,039 | 105.4 K to 105 K (-0.38 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.12 | 500 | 23,060 | 105,439 | 105.9 K to 105.4 K (-0.47 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.10 | 5 | 231 | 105,444 | 105.4 K to 105.4 K (0.00 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.09 | 100 | 4,609 | 105,944 | 106 K to 105.9 K (-0.09 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.08 | 300 | 13,824 | 106,044 | 106.3 K to 106 K (-0.28 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.07 | 2,800 | 128,996 | 106,344 | 109.1 K to 106.3 K (-2.57 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.07 | 100 | 4,607 | 109,144 | 109.2 K to 109.1 K (-0.09 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.06 | 1,700 | 78,302 | 109,244 | 110.9 K to 109.2 K (-1.53 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.06 | 13 | 599 | 110,944 | 111 K to 110.9 K (-0.01 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.06 | 305 | 14,047 | 110,957 | 111.3 K to 111 K (-0.27 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.05 | 3,387 | 155,971 | 111,262 | 114.6 K to 111.3 K (-2.95 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.05 | 103 | 4,743 | 114,649 | 114.8 K to 114.6 K (-0.09 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.04 | 1,106 | 50,920 | 114,752 | 115.9 K to 114.8 K (-0.95 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.04 | 2 | 92 | 115,858 | 115.9 K to 115.9 K (0.00 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.04 | 495 | 22,787 | 115,860 | 116.4 K to 115.9 K (-0.43 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.03 | 1,318 | 60,668 | 116,355 | 117.7 K to 116.4 K (-1.12 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.03 | 100 | 4,603 | 117,673 | 117.8 K to 117.7 K (-0.08 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.02 | 2,500 | 115,050 | 117,773 | 120.3 K to 117.8 K (-2.08 %) |